Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    vx15/2503
Show Display Options
Rank Status Study
1 Completed Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors
Condition: Solid Tumors
Intervention: Drug: VX15/2503
2 Active, not recruiting Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
Condition: Multiple Sclerosis
Interventions: Drug: VX15/2503;   Drug: Placebo

Indicates status has not been verified in more than two years